Literature DB >> 34802305

Antitumor activity of iRGD-modified red blood cell membrane nanoparticles loaded with Juglone and Oxaliplatin against colorectal cancer.

Jialei Mao1,2, Yinzhu Bian3, Qun Zhang4, Linghui Kong4, Xiao Shi4, Jing Hu4, Mi Yang4, Li Li4, Hanqing Qian4, Baorui Liu4, Xiaoping Qian4.   

Abstract

Entities:  

Keywords:  Juglone; Oxaliplatin; colorectal cancer; iRGD; nanoparticles

Mesh：

Substances：

Year:  2021        PMID： 34802305     DOI： 10.1177/08853282211052386

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN： 0885-3282            Impact factor:   2.646


× No keyword cloud information.
  2 in total

Review 1.  Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.

Authors:  Endong Zhang; Philana Phan; Hanan Ahmed Algarni; Zongmin Zhao
Journal:  Pharm Res       Date:  2022-07-07       Impact factor: 4.200

Review 2.  Recent advances in targeted drug delivery systems for resistant colorectal cancer.

Authors:  Masoumeh Sharifi-Azad; Marziyeh Fathi; William C Cho; Abolfazl Barzegari; Hamed Dadashi; Mehdi Dadashpour; Rana Jahanban-Esfahlan
Journal:  Cancer Cell Int       Date:  2022-05-19       Impact factor: 6.429
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.